Flebogamma 5% DIF IGIV

intravenous immunoglobulin · Instituto Grifols, S.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Flebogamma 5% DIF IGIV, covering 2016-12-08 to 2016-12-08. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of Flebogamma 5% DIF IGIV in Pediatric Subjects [Phase 4]